Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Winston Pharmaceuticals, Inc. (OP: WPHM)
0.0200 USD  UNCHANGED
Last Price  /  Updated: 8:10 PM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open -
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0200
Today's Range 0.0200 - 0.0200
52wk Range 0.0100 - 0.3500
Shares Outstanding 77,408,893
Dividend Yield N/A
Top News
More News
Winston Pharmaceuticals, Inc. Announces Positive Results of Phase II Clinical Trial of Dolorac® Nasal Solution
November 22, 2010
from Business Wire News Releases
Winston Pharmaceuticals, Inc. to Present at Lazard Capital Markets 7th Annual Healthcare Conference
November 10, 2010
from Business Wire News Releases

More News
Read More
Winston Laboratories, Inc. Receives Notice of Compliance in Canada for CIVANEX™ (Civamide Cream) for Treatment of Osteoarthritis
July 20, 2010
from Business Wire News Releases
Winston Laboratories, Inc. Submits NDA for CIVANEX® (Civamide Cream) for Treatment of Osteoarthritis
July 07, 2010
from Business Wire News Releases
Winston Laboratories, Inc. Announces Positive Top-line Results of Phase II Clinical Trial of Civamide Patch
November 16, 2009
from Business Wire News Releases
Winston Pharmaceuticals, Inc. to Present at Lazard Capital Markets 6th Annual Healthcare Conference
November 10, 2009
from Business Wire News Releases
Winston Laboratories, Inc. Receives Notice of Non-Compliance in Canada for its New Drug Submission of CIVANEX to Treat Osteoarthritis
October 19, 2009
from Business Wire News Releases
Winston Pharmaceuticals, Inc. Announces Re-Election of Joel E. Bernstein M.D. as President and Chief Executive Officer
August 14, 2009
from Business Wire News Releases
Winston Pharmaceuticals, Inc. Announces Election of New Chief Executive Officer and Chairman of the Board of Directors
July 28, 2009
from Business Wire News Releases
Winston Pharmaceuticals, Inc. Receives Orphan Drug Designation for Novel Patch to Treat Post-Herpetic Neuralgia
February 24, 2009
from Business Wire News Releases
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here